Skip to Main Content

FAAH Availability in Psychiatric Disorders: A PET Study

Conditions

Mental Health & Behavioral Research

Phase 0

What is the purpose of this trial?

The aim of the present study is to examine Fatty Acid Amide Hydrolase (FAAH) availability in humans, including healthy individuals and across a spectrum of psychiatric disorders in which alterations in the endocannabinoid system are observed.

  • Trial with
    Yale University School of Medicine
  • Start Date
    05/28/2020
  • End Date
    08/01/2023

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/17/2021
  • Study HIC
    #2000027585